GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1226 - 1250** of **4050** in total

« First

‹ Prev

…

46

47

48

49

50

51

52

53

54

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G68461PT	7416
IgM	Patient 3	4	mild	G68461PT	8644
IgA	Patient 4	12	mild	G68461PT	1354
IgG	Patient 4	12	mild	G68461PT	358
IgM	Patient 4	12	mild	G68461PT	1804
IgA	Patient 1	10	moderate	G67045LB	420
IgA	Patient 1	22	moderate	G67045LB	386
IgA	Patient 1	6	moderate	G67045LB	389
IgG	Patient 1	10	moderate	G67045LB	27
IgG	Patient 1	22	moderate	G67045LB	34
IgM	Patient 1	10	moderate	G67045LB	65
IgM	Patient 1	22	moderate	G67045LB	181
IgG	Patient 1	6	moderate	G67045LB	29
IgM	Patient 1	6	moderate	G67045LB	75
IgA	Patient 2	15	mild	G67045LB	341
IgA	Patient 2	24	mild	G67045LB	419
IgG	Patient 2	15	mild	G67045LB	33
IgG	Patient 2	24	mild	G67045LB	35
IgM	Patient 2	15	mild	G67045LB	127
IgM	Patient 2	24	mild	G67045LB	159
IgA	Patient 2	3	mild	G67045LB	431
IgG	Patient 2	3	mild	G67045LB	43
IgM	Patient 2	3	mild	G67045LB	233
IgA	Patient 3	-180	mild	G67045LB	275
IgA	Patient 3	11	mild	G67045LB	410